Insulet said results from its study of a fully closed-loop automated insulin delivery system for type 2 diabetes shows an improvement over standard injection therapy. Insulet said its system showed 68 ...
Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results